Matches in SemOpenAlex for { <https://semopenalex.org/work/W3156435441> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W3156435441 endingPage "S181" @default.
- W3156435441 startingPage "S144" @default.
- W3156435441 abstract ": Epithelial ovarian cancer (EOC) causes 60% of ovarian cancer cases and is the fourth most common cause of death from cancer in women. The standard of care for EOC includes a combination of surgery followed by intravenous chemotherapy. Intraperitoneal (IP) chemotherapy (CT) has been introduced into the therapeutic algorithm of EOC with positive results. To explore existing results regarding intraperitoneal chemotherapy a systematic review of the literature and an analysis of our own institutional prospective database of patients treated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC) for EOC at different stages were conducted. The focused report concerning our personal experience with advanced EOC treated with cytoreductive surgery and HIPEC produced the following results: In 57 patients cisplatin + paclitaxel as HIPEC was the only significant factor improving overall survival (OS) at multivariate analysis (OR 6.54, 95% CI: 1.24–34.47, P=0.027). Patients treated with HIPEC cisplatin + paclitaxel showed a median OS of 46 months (SD 6.4, 95% CI: 33.4–58.6), while patients treated with other HIPEC regimens showed a median OS of 12 months (SD 3.1, 95% CI: 6.0–18.0). The 2y-OS was 72% and 3y-OS was 68% for cisplatin + paclitaxel as HIPEC, while the 2y- and 3y-OS was 0% for other HIPEC regimens. Patients treated with HIPEC cisplatin + paclitaxel showed a median disease-free survival (DFS) of 13 months (SD 1.6, 95% CI: 9.9–16.1), while patients treated with other HIPEC regimens showed a median DFS of 8 months (SD 3.1, 95% CI: 1.9–14.1). In conclusion, HIPEC cisplatin + paclitaxel in ovarian cancer showed positive results that may be considered semi-definitive according to the level of evidence and should be considered a starting point for further investigations. At present HIPEC cisplatin + paclitaxel should be proposed to patients with advanced ovarian cancer as standard treatment at almost all stages of disease. Platinum + taxane-based intraperitoneal regimens demonstrated superior results compared to other regimens." @default.
- W3156435441 created "2021-04-26" @default.
- W3156435441 creator A5009522002 @default.
- W3156435441 creator A5019166100 @default.
- W3156435441 creator A5039819277 @default.
- W3156435441 creator A5058780088 @default.
- W3156435441 creator A5077313738 @default.
- W3156435441 date "2021-04-01" @default.
- W3156435441 modified "2023-10-18" @default.
- W3156435441 title "Intraperitoneal chemotherapy for ovarian cancer with peritoneal metastases, systematic review of the literature and focused personal experience" @default.
- W3156435441 doi "https://doi.org/10.21037/jgo-2020-06" @default.
- W3156435441 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8100719" @default.
- W3156435441 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33968435" @default.
- W3156435441 hasPublicationYear "2021" @default.
- W3156435441 type Work @default.
- W3156435441 sameAs 3156435441 @default.
- W3156435441 citedByCount "10" @default.
- W3156435441 countsByYear W31564354412021 @default.
- W3156435441 countsByYear W31564354412022 @default.
- W3156435441 countsByYear W31564354412023 @default.
- W3156435441 crossrefType "journal-article" @default.
- W3156435441 hasAuthorship W3156435441A5009522002 @default.
- W3156435441 hasAuthorship W3156435441A5019166100 @default.
- W3156435441 hasAuthorship W3156435441A5039819277 @default.
- W3156435441 hasAuthorship W3156435441A5058780088 @default.
- W3156435441 hasAuthorship W3156435441A5077313738 @default.
- W3156435441 hasBestOaLocation W31564354411 @default.
- W3156435441 hasConcept C121608353 @default.
- W3156435441 hasConcept C126322002 @default.
- W3156435441 hasConcept C141071460 @default.
- W3156435441 hasConcept C143998085 @default.
- W3156435441 hasConcept C2776694085 @default.
- W3156435441 hasConcept C2777292972 @default.
- W3156435441 hasConcept C2778239845 @default.
- W3156435441 hasConcept C2779458272 @default.
- W3156435441 hasConcept C2780427987 @default.
- W3156435441 hasConcept C2992773878 @default.
- W3156435441 hasConcept C2994223192 @default.
- W3156435441 hasConcept C3019901188 @default.
- W3156435441 hasConcept C71924100 @default.
- W3156435441 hasConceptScore W3156435441C121608353 @default.
- W3156435441 hasConceptScore W3156435441C126322002 @default.
- W3156435441 hasConceptScore W3156435441C141071460 @default.
- W3156435441 hasConceptScore W3156435441C143998085 @default.
- W3156435441 hasConceptScore W3156435441C2776694085 @default.
- W3156435441 hasConceptScore W3156435441C2777292972 @default.
- W3156435441 hasConceptScore W3156435441C2778239845 @default.
- W3156435441 hasConceptScore W3156435441C2779458272 @default.
- W3156435441 hasConceptScore W3156435441C2780427987 @default.
- W3156435441 hasConceptScore W3156435441C2992773878 @default.
- W3156435441 hasConceptScore W3156435441C2994223192 @default.
- W3156435441 hasConceptScore W3156435441C3019901188 @default.
- W3156435441 hasConceptScore W3156435441C71924100 @default.
- W3156435441 hasIssue "S1" @default.
- W3156435441 hasLocation W31564354411 @default.
- W3156435441 hasLocation W31564354412 @default.
- W3156435441 hasOpenAccess W3156435441 @default.
- W3156435441 hasPrimaryLocation W31564354411 @default.
- W3156435441 hasRelatedWork W2091372359 @default.
- W3156435441 hasRelatedWork W2112625834 @default.
- W3156435441 hasRelatedWork W2353198210 @default.
- W3156435441 hasRelatedWork W2784597821 @default.
- W3156435441 hasRelatedWork W2803553197 @default.
- W3156435441 hasRelatedWork W2953607890 @default.
- W3156435441 hasRelatedWork W2954241991 @default.
- W3156435441 hasRelatedWork W2955551170 @default.
- W3156435441 hasRelatedWork W2956145725 @default.
- W3156435441 hasRelatedWork W3168937214 @default.
- W3156435441 hasVolume "12" @default.
- W3156435441 isParatext "false" @default.
- W3156435441 isRetracted "false" @default.
- W3156435441 magId "3156435441" @default.
- W3156435441 workType "article" @default.